Edward Jones's Bannister Interview on J&J, Drug Stocks

Your next video will start in

Recommended Videos

  • Info

  • Comments

May 23 (Bloomberg) -- Linda Bannister, an analyst at Edward Jones & Co., talks about the outlook for U.S. pharmaceutical stocks. Johnson & Johnson, the drugmaker that won approval last week for the first new AIDS medicine since 2008, plans to introduce four drugs this year that may combine for annual sales of $9 billion, helping to offset product recalls and declining profit for medical devices. Bannister speaks on Bloomberg Television's "InBusiness with Margaret Brennan." (Source: Bloomberg)


BTV Channel Finder


ZIP is required for U.S. locations

Bloomberg Television in   change